1. |
Anam AK, Insogna K. Update on osteoporosis screening and management. Med Clin North Am, 2021, 105(6): 1117-1134.
|
2. |
Li J, Lu L, Liu Y, et al. Bone marrow adiposity during pathologic bone loss: molecular mechanisms underlying the cellular events. J Mol Med (Berl), 2022, 100(2): 167-183.
|
3. |
Zeng Q, Li N, Wang Q, et al. The prevalence of osteoporosis in China, a nationwide, multicenter DXA survey. J Bone Miner Res, 2019, 34(10): 1789-1797.
|
4. |
中华医学会骨质疏松和骨矿盐疾病分会. 原发性骨质疏松症诊疗指南(2022). 中华骨质疏松和骨矿盐疾病杂志, 2022, 15(6): 573-611.
|
5. |
庞国明, 武楠, 倪青. 成人原发性甲状腺功能减退症病证结合诊疗指南. 世界中医药, 2023, 18(16): 2265-2272.
|
6. |
中华医学会老年医学分会老年内分泌代谢疾病学组, 中华医学会内分泌学分会甲状腺学组. 中国老年人甲状腺疾病诊疗专家共识(2021). 中华内分泌代谢杂志, 2021, 37(5): 399-418.
|
7. |
Chaker L, Razvi S, Bensenor IM, et al. Hypothyroidism. Nat Rev Dis Primers, 2022, 8(1): 30.
|
8. |
Klubo-Gwiezdzinska J, Wartofsky L. Hashimoto thyroiditis: an evidence-based guide to etiology, diagnosis and treatment. Pol Arch Intern Med, 2022, 132(3): 16222.
|
9. |
Dosiou C. Thyroid and fertility: recent advances. Thyroid, 2020, 30(4): 479-486.
|
10. |
Kim BY, Kim SS, Park HK, et al. Assessment of the relationship between knee ultrasound and clinical symptoms in patients with thyroid dysfunction. J Int Med Res, 2020, 48(1): 300060519897701.
|
11. |
Bojikian KD, Francis CE. Thyroid eye disease and myasthenia gravis. Int Ophthalmol Clin, 2019, 59(3): 113-124.
|
12. |
Ahmadi N, Ahmadi F, Sadiqi M, et al. Thyroid gland dysfunction and its effect on the cardiovascular system: a comprehensive review of the literature. Endokrynol Pol, 2020, 71(5): 466-478.
|
13. |
Branstetter RT, Islam RK, Toups CA, et al. Mechanisms and treatment options for hyperthyroid-induced osteoporosis: a narrative review. Cureus, 2023, 15(11): e48798.
|
14. |
Vandenbroucke A, Luyten FP, Flamaing J, et al. Pharmacological treatment of osteoporosis in the oldest old. Clin Interv Aging, 2017, 12: 1065-1077.
|
15. |
Delitala AP, Scuteri A, Doria C. Thyroid hormone diseases and osteoporosis. J Clin Med, 2020, 9(4): 1034.
|
16. |
Wu J, Huang H, Yu X. How does Hashimoto’s thyroiditis affect bone metabolism?. Rev Endocr Metab Disord, 2023, 24(2): 191-205.
|
17. |
Li P, Wang H, Guo L, et al. Association between gut microbiota and preeclampsia-eclampsia: a two-sample Mendelian randomization study. BMC Med, 2022, 20(1): 443.
|
18. |
Boef AG, Dekkers OM, le Cessie S. Mendelian randomization studies: a review of the approaches used and the quality of reporting. Int J Epidemiol, 2015, 44(2): 496-511.
|
19. |
Tachmazidou I, Hatzikotoulas K, Southam L, et al. Identification of new therapeutic targets for osteoarthritis through genome-wide analyses of UK Biobank data. Nat Genet, 2019, 51(2): 230-236.
|
20. |
Verbanck M, Chen CY, Neale B, et al. Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nat Genet, 2018, 50(5): 693-698.
|
21. |
Burgess S, Bowden J, Fall T, et al. Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants. Epidemiology, 2017, 28(1): 30-42.
|
22. |
Burgess S, Thompson SG. Interpreting findings from Mendelian randomization using the MR-Egger method. Eur J Epidemiol, 2017, 32(5): 377-389.
|
23. |
刘明, 高亚, 杨珂璐, 等. 孟德尔随机化研究的报告规范(STROBE-MR)解读. 中国循证医学杂志, 2022, 22(8): 978-987.
|
24. |
Sobh MM, Abdalbary M, Elnagar S, et al. Secondary osteoporosis and metabolic bone diseases. J Clin Med, 2022, 11(9): 2382.
|
25. |
Williams GR, Bassett JHD. Thyroid diseases and bone health. J Endocrinol Invest, 2018, 41(1): 99-109.
|
26. |
Bassett JH, Williams GR. Role of thyroid hormones in skeletal development and bone maintenance. Endocr Rev, 2016, 37(2): 135-187.
|
27. |
Duncan Bassett JH, Williams GR. Analysis of physiological responses to thyroid hormones and their receptors in bone. Methods Mol Biol, 2018, 1801: 123-154.
|
28. |
Obling ML, Nicolaisen P, Brix TH, et al. Restoration of euthyroidism in women with Hashimoto’s thyroiditis changes bone microarchitecture but not estimated bone strength. Endocrine, 2021, 71(2): 397-406.
|
29. |
Thayakaran R, Adderley NJ, Sainsbury C, et al. Thyroid replacement therapy, thyroid stimulating hormone concentrations, and long term health outcomes in patients with hypothyroidism: longitudinal study. BMJ, 2019, 366: l4892.
|
30. |
郑家深, 张源, 杨培庆, 等. 甲状腺功能异常对男性骨密度影响的研究. 中国骨质疏松杂志, 2020, 26(6): 885-888.
|
31. |
Tuchendler D, Bolanowski M. Assessment of bone metabolism in premenopausal females with hyperthyroidism and hypothyroidism. Endokrynol Pol, 2013, 64(1): 40-44.
|
32. |
Teng W. Levothyroxine and bone//Kahaly GJ. 70 years of levothyroxine. Cham (CH): Springer International Publishing AG, 2021: 97-107.
|
33. |
Karimifar M, Esmaili F, Salari A, et al. Effects of levothyroxine and thyroid stimulating hormone on bone loss in patients with primary hypothyroidism. J Res Pharm Pract, 2014, 3(3): 83-87.
|
34. |
高城翰, 关雪峰, 高天舒. 含富碘中药复方对 Graves 病致骨质疏松症的治疗作用. 中华中医药学刊, 2021, 39(8): 192-194.
|
35. |
Wang H, Wu J, Wang B, et al. Progress in prevention and treatment of acute bone loss in orthopedics. Int J Endocrinol, 2023, 2023: 9373043.
|
36. |
Srivastava RK, Sapra L. The rising era of “immunoporosis”: role of immune system in the pathophysiology of osteoporosis. J Inflamm Res, 2022, 15: 1667-1698.
|
37. |
Lademann F, Tsourdi E, Hofbauer LC, et al. Thyroid hormone actions and bone remodeling - the role of the Wnt signaling pathway. Exp Clin Endocrinol Diabetes, 2020, 128(6-07): 450-454.
|
38. |
宋慧芳. 绝经后女性桥本甲状腺炎与骨密度的相关性研究. 青岛: 青岛大学, 2021.
|
39. |
Demartini Ade A, Kulak CA, Borba VC, et al. Bone mineral density of children and adolescents with congenital hypothyroidism. Arq Bras Endocrinol Metabol, 2007, 51(7): 1084-1092.
|
40. |
Abe E, Marians RC, Yu W, et al. TSH is a negative regulator of skeletal remodeling. Cell, 2003, 115(2): 151-162.
|